H. Zeidler

发表

Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection

H. Gérard, J. Whittum-Hudson, A. Hudson, 2001, Molecular microbiology.

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

H. Zeidler, W. Golder, A. Krause, 2002, The Lancet.

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

P. Emery, P. V. van Riel, G. Burmester, 2003, Annals of the rheumatic diseases.

Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.

J. Kovarik, H. Zeidler, R. Alten, 1996, The Journal of rheumatology.

Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: a literature review.

H. Zeidler, M. Brenner, W. Mau, 1997, Seminars in arthritis and rheumatism.

Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings.

H. Zeidler, R. Schmidt, T. Mittendorf, 2011, Rheumatology.

Early arthritis and rheumatoid arthritis in Germany.

H. Zeidler, J. Hülsemann, S. Merkesdal, 2003, Clinical and experimental rheumatology.

Indirect medical costs in the first 3 years of rheumatoid arthritis: comparison of current methodological approaches

H. Zeidler, T. Mittendorf, W. Mau, 2002, Expert review of pharmacoeconomics & outcomes research.

Psychological stress in rheumatoid arthritis patients: a comparative Polish-German study: summary of the current conceptualization of the role of stress in rheumatoid arthritis.

H. Zeidler, J. Bugajska, D. Żołnierczyk-Zreda, 2010, Autoimmunity reviews.

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

D. Huscher, H. Zeidler, A. Zink, 2006, Annals of the rheumatic diseases.

H. Zeidler, J. Hülsemann, T. Mittendorf, 2005, Annals of the rheumatic diseases.

Production of prostaglandin E2 in monocytes stimulated in vitro by Chlamydia trachomatis, Chlamydophila pneumoniae, and Mycoplasma fermentans.

B. Krausse-Opatz, H. Zeidler, L. Köhler, 2004, Microbial pathogenesis.

How does Chlamydia cause arthritis?

H. Zeidler, L. Köhler, J. Kuipers, 2003, Rheumatic diseases clinics of North America.

[Rheumatology: Integration into student training--the RISA- Study. Results of a survey exploring the scale of education and training in rheumatology at German universities].

H. Zeidler, J. Zacher, G. Keyßer, 2004, Zeitschrift fur Rheumatologie.

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

M. Dougados, F. Breedveld, P. Brooks, 1999, Rheumatology.

Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-α in vitro

H. Zeidler, L. Köhler, A. Liese, 2004, Medical Microbiology and Immunology.

Ro 15-8081 in osteoarthritis of hip and knee: a double-blind placebo-controlled multicentre dose-ranging study on analgesia

M. Dougados, H. Zeidler, Dominique Bolnot-Delmas, 1996, Pain.

The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?

H. Zeidler, 2014, Annals of the rheumatic diseases.

Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standards

Henning Zeidler, Thomas Mittendorf, Jan L. Hülsemann, 2004, The European Journal of Health Economics, formerly: HEPAC.

Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis.

H. Zeidler, A. Maetzel, W. Mau, 2001, The Journal of rheumatology.

Cost assessment instrument in rheumatology: evaluation of applied instrument characteristics.

H. Zeidler, A. Maetzel, W. Mau, 2001, The Journal of rheumatology.

Characterization of a soluble form of CD58 in synovial fluid of patients with rheumatoid arthritis (RA)

H. Zeidler, J. Hoffmann, B. Bayer, 1996, Clinical and experimental immunology.

Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus

H. Zeidler, H. Peter, T. Witte, 2006, Annals of the rheumatic diseases.

H. Zeidler, H. Deicher, K. Hartung, 1993, Clinical Rheumatology.

Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.

R. Rau, S. Wassenberg, H. Zeidler, 2005, Arthritis and rheumatism.

Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis.

A. Hudson, H. Zeidler, E. Gromnica-ihle, 2003, Clinical and experimental rheumatology.

Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells.

H. Gérard, A. Hudson, H. Zeidler, 2000, Arthritis and rheumatism.

Undifferentiated spondyloarthropathies.

H. Zeidler, M. Khan, W. Mau, 1992, Rheumatic diseases clinics of North America.

Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis

H. Zeidler, J. Lotz, E. Raum, 2004, Annals of the rheumatic diseases.

Combined Add-on Supplementation of Omega-3 Fatty Acids, Vitamin E, Vitamin A, Copper, and Selenium in Rheumatoid Arthritis

H. Zeidler, B. Uehleke, R. Lichtinghagen, 2011 .

Intravenous Glucocorticoid Pulse Therapy in Active, NSAID Refractory Axial An

H. Zeidler, R. Schmidt, M. Rihl, 2018 .

Peripheral Arthritis in Patients Classified as Having Nonradiographic Axial Spondyloarthritis in Trials of Anti–Tumor Necrosis Factor Agents: Comment on the Article by Dougados et al

H. Zeidler, 2015, Arthritis & rheumatology.

Time to prove the infective etiology of ankylosing spondylitis and related spondylarthritides: Comment on the article by Carter et al.

H. Zeidler, M. Rihl, 2009, Arthritis and rheumatism.

Cytokine profile in serum and synovial fluid of arthritis patients with Chlamydia trachomatis infection

H. Zeidler, L. Köhler, E. Raum, 2003, Rheumatology International.

Evaluation of amplicor chlamydia PCR and LCX chlamydia LCR to detect Chlamydia trachomatis in synovial fluid.

H. Zeidler, L. Köhler, J. Wollenhaupt, 2002, Clinical and experimental rheumatology.

Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study.

H. Zeidler, J. Wollenhaupt, J. Kuipers, 2001, Arthritis and rheumatism.

HLA-B27 in possible ankylosing spondylitis with peripheral arthritis

H. Zeidler, H. Deicher, P. Wagener, 2004, Rheumatology International.

HLA‐B27 and Clinical Aspects of Ankylosing Spondylitis: Results of Prospective Studies

H. Zeidler, H. Deicher, P. Wagener, 1985, Immunological reviews.

A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis

R. Rau, H. Zeidler, M. Schattenkirchner, 1990, Clinical Rheumatology.

Outcome of possible ankylosing spondylitis in a 10 years' follow-up study

H. Zeidler, H. Deicher, W. Mau, 1987, Clinical Rheumatology.

Epidemiology of NSAID-induced gastropathy

H. Zeidler, 1991, Clinical Rheumatology.

Epidemiology and economics of NSAID-induced gastropathy.

H. Zeidler, 1992, Scandinavian journal of rheumatology. Supplement.

Psoriatic Spondylitis: A Disease Manifestation in Debate: Evidences to Know for the Clinical Rheumatologist.

H. Zeidler, 2022, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Acute coronary syndrome associated with Churg-Strauss syndrome

H. Zeidler, H. Haller, J. Lotz, 2007, Vascular health and risk management.

Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research

A. Hudson, H. Zeidler, 2016, Current Rheumatology Reports.

Effects of Azithromycin and Rifampin onChlamydia trachomatis Infection In Vitro

H. Zeidler, L. Köhler, U. Dreses-Werringloer, 2001, Antimicrobial Agents and Chemotherapy.

Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.

H. Gérard, J. Whittum-Hudson, A. Hudson, 2002, Microbes and infection.

Persistence of Chlamydia trachomatis Is Induced by Ciprofloxacin and Ofloxacin In Vitro

A. Hudson, H. Zeidler, L. Köhler, 2000, Antimicrobial Agents and Chemotherapy.

Microbe-induced T cell apoptosis: subversion of the host defense system?

H. Zeidler, L. Köhler, J. Kuipers, 2002, FEMS microbiology letters.

Comment on: Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?

H. Zeidler, E. Feldtkeller, 2016, Rheumatology.

The historical concept of interrelated conditions grouped together as a family of distinct diseases is not outdated: comment on the article by Baeten et al.

H. Zeidler, 2013, Arthritis and rheumatism.

Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup.

H. Zeidler, H. Deicher, W. Stangel, 1988, The Journal of rheumatology.

How can misclassification be prevented when using the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria? Comment on the article by van der Linden et al.

H. Zeidler, 2011, Arthritis and rheumatism.

The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis

H. Zeidler, J. Listing, A. Zink, 2001, Annals of the rheumatic diseases.

The Need to Better Classify and Diagnose Early and Very Early Rheumatoid Arthritis

H. Zeidler, 2012, The Journal of Rheumatology.

Transmission of Chlamydophila pneumoniae from dendritic cells to macrophages does not require cell-to-cell contact in vitro.

A. Hudson, B. Krausse-Opatz, H. Zeidler, 2008, Journal of microbiological methods.

Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

H. Zeidler, J. Listing, A. Zink, 2005, The Journal of rheumatology.

Free iron ions decrease indoleamine 2,3-dioxygenase expression and reduce IFNgamma-induced inhibition of Chlamydia trachomatis infection.

D. Tsikas, B. Krausse-Opatz, H. Zeidler, 2009, Microbial pathogenesis.

Cost-effectiveness of TNF-α-blocking agents in the treatment of rheumatoid arthritis

H. Zeidler, T. Mittendorf, J. Ruof, 2004, Expert opinion on pharmacotherapy.

Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.

R. Rau, H. Zeidler, M. Schattenkirchner, 1982, The Journal of rheumatology. Supplement.

[Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].

H. Raspe, F. Buttgereit, H. Zeidler, 2011, Zeitschrift fur Rheumatologie.

Staining of Chlamydia trachomatis elementary bodies: a suitable method for identifying infected human monocytes by flow cytometry.

A. Thiel, H. Zeidler, A. Liese, 2007, Journal of microbiological methods.

Infection and musculoskeletal conditions: Lyme borreliosis.

H. Zeidler, A. Krause, J. Franz, 2006, Best practice & research. Clinical rheumatology.

[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].

H. Zeidler, E. Gromnica-ihle, A. Zink, 2004, Zeitschrift fur Rheumatologie.

[Early diagnosis of arthritis and spondyloarthritis within the framework of integrated health care in Lower Saxony].

S. Mattussek, H. Zeidler, J. Hülsemann, 2006, Zeitschrift fur Rheumatologie.

TNF-blocking therapy in rheumatoid arthritis and ankylosing spondylitis: Why is cost-effectiveness a major issue?

H. Zeidler, S. Merkesdal, 2005, Current rheumatology reports.

Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension

P. Hannonen, H. Zeidler, I. Hafström, 2002, Annals of the rheumatic diseases.

Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.

H. Zeidler, T. Mittendorf, W. Mau, 2005, Arthritis and rheumatism.

TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis

H. Zeidler, R. Jacobs, R. Schmidt, 2004, Rheumatology International.

Follow-up of Patients with Double Stranded DNA Antibodies Induced by Sutfasalazine during the Treatment of Inflammatory Rheumatic Diseases

H. Zeidler, W. Mau, K. Wildhagen, 1993 .

Antibiotic treatment of Lyme borreliosis: what is the evidence?

H. Zeidler, R. Dinser, M. Jendro, 2005, Annals of the rheumatic diseases.

A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial.

R. Rau, S. Wassenberg, H. Zeidler, 2011, Clinical and experimental rheumatology.

Chlamydia-induced arthritis

H. Zeidler, L. Köhler, J. Kuipers, 2004, Current opinion in rheumatology.

Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma.

E. Märker-Hermann, H. Zeidler, D. Baeten, 2004, Annals of the rheumatic diseases.

Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction.

H. Zeidler, L. Köhler, J. Wollenhaupt, 1998, Arthritis and rheumatism.

Coinfection of Chlamydiae and other Bacteria in Reactive Arthritis and Spondyloarthritis: Need for Future Research

A. Hudson, H. Zeidler, 2016, Microorganisms.

Nephrotoxicity of selective COX-2 inhibitors.

A. Schwarz, H. Zeidler, L. Köhler, 2001, The Journal of rheumatology.

Infection of Human Monocyte-Derived Macrophages with Chlamydia trachomatis Induces Apoptosis of T Cells: a Potential Mechanism for Persistent Infection

B. Krausse-Opatz, H. Zeidler, L. Köhler, 2000, Infection and Immunity.

Specific serum IgA-antibodies in chlamydial-induced arthritis.

H. Zeidler, T. Krech, C. Schneider, 1989, Zeitschrift fur Rheumatologie.

Bacterial triggers and autoimmune rheumatic diseases.

Y. Shoenfeld, H. Zeidler, L. Guilherme, 2008, Clinical and experimental rheumatology.

Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis.

J. Heesemann, H. Zeidler, M. Hammer, 1990, Arthritis and rheumatism.

Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis.

H. Zeidler, S. Hopf, M. Hammer, 1992, Clinical and experimental rheumatology.

Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis.

G. Stanek, H. Zeidler, M. Follmann, 1995, Arthritis and rheumatism.

Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid

H. Zeidler, J. Wollenhaupt, K. Scharmann, 1995, Journal of clinical microbiology.

Optimized testing for C. trachomatis DNA in synovial fluid samples in clinical practice

H. Zeidler, J. Freise, J. Kuipers, 2015, Zeitschrift für Rheumatologie.

Persistent infection of Chlamydia in reactive arthritis

H. Zeidler, L. Köhler, A. Klos, 2006, Annals of the rheumatic diseases.

Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.

Matthias Schneider, G. Burmester, H. Zeidler, 2007, The Journal of rheumatology.

Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid α-naphthyl esterase staining

H. Zeidler, W. Pichler, H. Peter, 2004, Rheumatology International.

Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic

H. Zeidler, J. Hülsemann, J. Hulsemann, 1999, Annals of the rheumatic diseases.

Claims Data Analysis of Tumor Necrosis Factor Inhibitor Treatment Dosing Among Patients with Rheumatoid Arthritis: A Systematic Review of Methods

H. Zeidler, J. Zeidler, G. Krack, 2016, Drugs - Real World Outcomes.

Unilateral Fasciitis of the Lower Leg: A Paraneoplastic Manifestation of an Occult Pancreatic Tumor

H. Zeidler, L. Köhler, S. Pertschy, 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis –

R. Rau, H. Zeidler, for the LDPT-Study Group, 2000, Zeitschrift für Rheumatologie.

Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study

H. Zeidler, T. Kirchhoff, M. Pfreundschuh, 2009, Arthritis research & therapy.

Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up

M. Prokop, M. Hammer, M. Galanski, 2003, European Radiology.

Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome.

H. Zeidler, J. Hülsemann, J. Andresen, 2002, Arthritis and rheumatism.

Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis.

M. Dougados, A. Calin, J. Nakache, 1999, The Journal of rheumatology.

Increased frequency of HLA-Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis.

H. Zeidler, H. Deicher, P. Wagener, 1983, British journal of rheumatology.

Undifferentiated arthritis and spondylarthropathy as a major problem of diagnosis and classification.

H. Zeidler, 1987, Scandinavian journal of rheumatology. Supplement.

Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes.

H. Gérard, A. Hudson, H. Zeidler, 1997, Microbial pathogenesis.

Easy probability estimation of the diagnosis of early axial spondyloarthritis by summing up scores.

H. Zeidler, M. Rudwaleit, E. Feldtkeller, 2013, Rheumatology.

Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany.

C. Baerwald, H. Zeidler, A. Neubauer, 2013, Clinical and experimental rheumatology.

Unproven hypothesis that leflunomide is better than methotrexate as measured by magnetic resonance imaging: comment on the article by Reece et al.

H. Zeidler, J. Hülsemann, S. Schnarr, 2003, Arthritis and rheumatism.

Intracellular persistence of chlamydial major outer-membrane protein, lipopolysaccharide and ribosomal RNA after non-productive infection of human monocytes with Chlamydia trachomatis serovar K.

E. Manor, H. Zeidler, J. Wollenhaupt, 1993, Journal of medical microbiology.

Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.

S. Ziemer, H. Zeidler, J. Listing, 2001, The Journal of rheumatology.

Circulating immune complexes in ankylosing spondylitis.

H. Zeidler, H. Deicher, A. Ebringer, 1983, British journal of rheumatology.

Third Eular Workshop on Rheumatology Research

C. Forbes, R. Madhok, A. Cats, 1983, Clinical Rheumatology.

Niki de Saint Phalle's lifelong dialogue between art and diseases: psychological trauma of sexual abuse, transient selective IgA deficiency, occupational exposure to toxic plastic material, chronic lung disease, rheumatoid arthritis.

H. Zeidler, 2013, Joint, bone, spine : revue du rhumatisme.

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison

P. Isakson, P. Emery, H. Zeidler, 1999, The Lancet.

Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: A one-year, double-blind, comparative multicenter study

R. Rau, H. Zeidler, M. Schattenkirchner, 1988, Klinische Wochenschrift.

Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.

M. Manns, H. Zeidler, K. Böker, 1997, Journal of hepatology.

Managing seronegative spondarthritides.

H. Zeidler, J. Kuipers, L. Koehler, 2000, Rheumatology.

The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

E. Märker-Hermann, H. Zeidler, J. Braun, 2009, Arthritis and rheumatism.

Relation of HLA-B27, Tumor Necrosis Factor-α Promoter Gene Polymorphisms, and T Cell Cytokine Production in Ankylosing Spondylitis — A Comprehensive Genotype-Phenotype Analysis from an Observational Cohort

E. Märker-Hermann, H. Zeidler, J. Braun, 2011, The Journal of Rheumatology.

Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.

H. Zeidler, G. Burmester, G. Burmester, 2005, Rheumatology.

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

H. Zeidler, G. Burmester, G. Burmester, 2004, Annals of the rheumatic diseases.

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.

M. Dougados, A. Calin, I. Olivieri, 2005, Arthritis and rheumatism.

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.

M. Dougados, A. Calin, I. Olivieri, 2001, Arthritis and rheumatism.

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

E. Märker-Hermann, H. Zeidler, J. Braun, 2012, Annals of the rheumatic diseases.

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.

H. Zeidler, G. Burmester, W. Golder, 2003, Arthritis and rheumatism.

CASE REPORT: A Rare Manifestation of Behçet's Syndrome: Immunological Correlates and Successful Treatment of an Esophageal Ulcer

M. Manns, H. Zeidler, M. Mengel, 2003, Digestive Diseases and Sciences.

Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens

A. Hudson, H. Zeidler, 2021, Current Rheumatology Reports.

Quo vadis reactive arthritis?

A. Hudson, H. Zeidler, 2022, Current opinion in rheumatology.

Clinical images: Hypertrophic osteoarthropathy.

M. Galanski, H. Zeidler, K. Gratz, 1999, Arthritis and rheumatism.

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

M. Boers, J. Jacobs, J. Kirwan, 2007, Annals of the rheumatic diseases.

Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34

H. Zeidler, J. Westermann, B. Bayer, 1997, Annals of the rheumatic diseases.

Improvement of Erdheim–Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil

A. Schwarz, H. Zeidler, H. Haller, 2004, Clinical Rheumatology.

Complicated Cogan's syndrome with aortic insufficiency and coronary stenosis.

H. Zeidler, R. Laszig, T. Witte, 1994, The Journal of rheumatology.

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany

Matthias Schneider, H. Zeidler, E. Gromnica-ihle, 2012, PharmacoEconomics.

Specificities of human TAP alleles for HLA-B27 binding peptides.

H. Zeidler, D. Yu, R. Raybourne, 1996, Arthritis and rheumatism.

HUMAN B CELL DIFFERENTIATION: DEPENDENCE ON INTERACTIONS WITH MONOCYTES AND T LYMPHOCYTES VIA CD40, CD80 (B7.1), AND THE CD2‐LIGANDS CD48 AND CD58 (LFA‐3)

H. Zeidler, S. Zielen, J. Hoffmann, 1998, Cell biology international.

Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy

H. Zeidler, D. Baeten, E. Veys, 2004, Annals of the rheumatic diseases.

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Andreas Krause, M. Baumgaertner, H. Zeidler, 2006, Annals of the rheumatic diseases.

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.

M. Dougados, R. Juhlin, B. Huitfeldt, 1995, Arthritis and rheumatism.

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

E. Märker-Hermann, H. Zeidler, J. Braun, 2011, Annals of the rheumatic diseases.

Managing seronegative spondarthritides How can we overcome the outdated classiﬁcation of ‘seronegative arthritis’ by a rational, cost-e ﬀ ective diagnostic strategy?

H. Zeidler, J. Kuipers, L. Koehler, 2000 .

Aetiological agents: their molecular biology and phagocyte-host interaction.

A. Hudson, H. Zeidler, L. Koehler, 1998, Bailliere's clinical rheumatology.

Fate of Chlamydophila pneumoniae in human monocyte-derived dendritic cells: long lasting infection.

M. Zenke, H. Gérard, A. Hudson, 2006, Microbial pathogenesis.

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

M. Dougados, A. Calin, J. Nakache, 1999, Rheumatology.

Undifferentiated arthritis in an early synovitis out-patient clinic.

H. Zeidler, J. Hülsemann, 1995, Clinical and experimental rheumatology.

Detection of Chlamydia trachomatis-DNA in synovial fluid: evaluation of the sensitivity of different DNA extraction methods and amplification systems

H. Zeidler, J. Freise, J. Kuipers, 2009, Arthritis research & therapy.

Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis

M. Dougados, T. Vischer, H. Zeidler, 2008, Clinical Rheumatology.

Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-gamma.

H. Zeidler, L. Köhler, U. Dreses-Werringloer, 1998, Journal of medical microbiology.

Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.

E. Märker-Hermann, H. Zeidler, J. Braun, 2012, Arthritis and rheumatism.

Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone.

H. Zeidler, J. Frölich, J. Fauler, 1995, Annals of the rheumatic diseases.

OP0063 Three months results of a double-blind placebo controlled, phase-iii clinical trial of infliximab in active ankylosing spondylitis

H. Zeidler, G. Burmester, E. Gromnica-ihle, 2001 .

Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.

M. Dougados, A. Calin, J. Nakache, 1999, Rheumatology.

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Andreas Krause, H. Zeidler, G. Burmester, 2007, Annals of the rheumatic diseases.

A historical perspective of the spondyloarthritis

B. Amor, A. Calin, H. Zeidler, 2011, Current opinion in rheumatology.

Nodular fasciitis, erythema migrans, and oligoarthritis: manifestations of Lyme borreliosis caused by Borrelia afzelii

H. Zeidler, H. Kreipe, M. Mengel, 2002, Scandinavian journal of rheumatology.

Anti‐CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down‐modulation

H. Zeidler, J. Westermann, J. Hoffmann, 1997, Clinical and experimental immunology.

Anti-CD 2 ( OX 34 ) MoAb treatment of adjuvant arthritic rats : attenuation of established arthritis , selective depletion of CD 4 þ T cells , and CD 2 down-modulation

H. Zeidler, J. Westermann, J. Hoffmann, 1997 .

Effects of the Anti‐CD2 mAb OX34 on in Vivo Proliferation

M. Zeitz, H. Zeidler, J. Westermann, 1998, Annals of the New York Academy of Sciences.

Association of an NKG2D gene variant with systemic lupus erythematosus in two populations.

Javier Martín, H. Zeidler, S. Buyny, 2010, Human immunology.

Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.

H. Zeidler, F. Degner, R. Sigmund, 2000, Clinical therapeutics.

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment

H. Zeidler, D. Baeten, F. Keyser, 2005, Annals of the rheumatic diseases.

Follow-up of patients with double stranded DNA antibodies induced by sulfasalazine during the treatment of inflammatory rheumatic diseases.

H. Zeidler, W. Mau, K. Wildhagen, 1993, Scandinavian Journal of Rheumatology.

Expression of inflammatory host genes in Chlamydia trachomatis-infected human monocytes

H. Zeidler, S. Hess, A. Klos, 2007, Arthritis research & therapy.

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

H. Zeidler, J. Listing, A. Zink, 2001, Annals of the rheumatic diseases.

Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial

H. Zeidler, J. Wollenhaupt, J. Kuipers, 2006, Annals of the rheumatic diseases.

Reactive or infectious arthritis

H. Zeidler, L. Köhler, J. Kuipers, 1999, Annals of the rheumatic diseases.

New insights into Chlamydia and arthritis. Promise of a cure?

A. Hudson, H. Zeidler, 2013, Annals of the rheumatic diseases.

Combination antibiotics for Chlamydia-induced arthritis: breakthrough to a cure?

H. Zeidler, L. Köhler, M. Rihl, 2010, Arthritis and rheumatism.

The molecular pathogenesis of Chlamydia-induced arthritis: Where do we stand?

H. Zeidler, M. Rihl, 2007, Current rheumatology reports.

[Final report of the Professional Community of Regional Cooperative Rheumatology Centers of Germany concerning model measures of the federal ministry for public health].

H. Zeidler, I. Meznerits, 2002, Zeitschrift fur Rheumatologie.

Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis

B. Krausse-Opatz, H. Zeidler, L. Köhler, 2007, Medical Microbiology and Immunology.

Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes

H. Gérard, A. Hudson, H. Zeidler, 1998, Medical Microbiology and Immunology.

Optimised sample DNA preparation for detection ofChlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction

H. Gérard, J. Whittum-Hudson, A. Hudson, 2001, Annals of the rheumatic diseases.

Optimised sample preparation of synovial fluid for detection ofChlamydia trachomatis DNA by polymerase chain reaction

H. Zeidler, U. Dreses-Werringloer, J. Kuipers, 1999, Annals of the rheumatic diseases.

Patient-reported health care utilization in rheumatoid arthritis: what level of detail is required?

Henning Zeidler, Thomas Mittendorf, H. Zeidler, 2004, Arthritis and rheumatism.

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources

H. Zeidler, J. Hülsemann, T. Mittendorf, 2003, Annals of the rheumatic diseases.

Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy

H. Zeidler, J. Kuipers, S. Schnarr, 2002 .

Great Artists With Rheumatoid Arthritis. What Did Their Disease and Coping Teach?: Part II. Raoul Dufy and Niki de Saint Phalle

H. Zeidler, 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Great artists with rheumatoid arthritis: what did their disease and coping teach? Part I. Pierre-Auguste Renoir and Alexej von Jawlensky.

H. Zeidler, 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Auguste Renoir, Sculptor With Hired Hands: A Masterful Artistic Cooperation Overshadowed by Legal Issues and Copyright Infringement

H. Zeidler, 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

["Memories of my sick hands": life and medical history of the painter Alexej von Jawlensky].

H. Zeidler, 2011, Zeitschrift fur Rheumatologie.

Efficacy and safety of the fully human anti-tumour necrosis factor a monoclonal antibody adalimumab ( D 2 E 7 ) in DMARD refractory patients with rheumatoid arthritis : a 12 week , phase II study

P. Emery, G. Burmester, R. Rau, 2003 .

Chlamydia-Induced Reactive Arthritis: Disappearing Entity or Lack of Research?

A. Hudson, H. Zeidler, 2019, Current Rheumatology Reports.

Detection of chlamydial DNA in the inflamed sacroiliac joint of a patient with multiple infections.

H. Zeidler, L. Köhler, M. Bernateck, 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC)

E. Märker-Hermann, H. Zeidler, J. Braun, 2013, Annals of the rheumatic diseases.

[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire].

T. Kohlmann, H. Raspe, H. Zeidler, 1997, Zeitschrift fur Rheumatologie.

Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).

H. Raspe, Matthias Schneider, H. Zeidler, 2009, Rheumatology.

Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

S Merkesdal, O Schöffski, H. Zeidler, 2001, Arthritis and rheumatism.

Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.

P. Hannonen, H. Zeidler, I. Hafström, 1998, British journal of rheumatology.

Implementing standardized cost categories within economic evaluations in musculoskeletal diseases

H. Zeidler, T. Mittendorf, J. G. von der Schulenburg, 2003, The European Journal of Health Economics.

[Classification criteria for rheumatic diseases].

H. Zeidler, 2016, Zeitschrift fur Rheumatologie.

Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries

D. Cucinotta, A. Woolf, U. Haglund, 2004, Annals of the rheumatic diseases.

Development of a Matrix

H. Zeidler, A. Maetzel, J. Ruof, 2004 .

[Pathogenesis of ankylosing spondylitis-mechanisms of disease manifestation and chronicity].

E. Märker-Hermann, H. Zeidler, J. Sieper, 2004, Zeitschrift fur Rheumatologie.

Evaluation of ELISA to detect Chlamydia trachomatis antigen in urine samples from arthritis patients.

H. Zeidler, L. Köhler, M. Frosch, 1997, Clinical and experimental rheumatology.

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

M. Dougados, R. Rau, H. Zeidler, 1999, Annals of the rheumatic diseases.

Paracetamol and the Placebo Effect in Osteoarthritis Trials: A Missing Link?

H. Zeidler, 2011, Pain research and treatment.

How should best strategy and tight control be translated into clinical practice? Comment on the article by Goekoop-Ruiterman et al.

H. Zeidler, J. Hülsemann, 2006, Arthritis and rheumatism.

Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis

Henning Zeidler, Dominique Baeten, Roland Jacobs, 2009, Arthritis research & therapy.

Recent advances in diagnosis and comprehensive management of more general spinal disorders.

H. Zeidler, D. Borenstein, 2002, Best practice & research. Clinical rheumatology.

Rationale for the use of cyclooxygenase-2-specific nonsteroidal antiinflammatory drugs in ankylosing spondylitis: the available evidence

H. Zeidler, J. Kuipers, Lars Köehler, 2003, Current Rheumatology Reports.

Prescription and Tolerability of Meloxicam in Day-to-Day Practice: Postmarketing Observational Cohort Study of 13,307 Patients in Germany

T. Kohlmann, H. Zeidler, F. Degner, 2002, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Safety of celecoxib vs other nonsteroidal anti-inflammatory drugs.

H. Zeidler, L. Köhler, S. Merkesdal, 2000, JAMA.

Intra-articular co-infection by Borrelia burgdorferi and Chlamydia trachomatis

H. Zeidler, J. Wollenhaupt, J. Kuipers, 2001, Annals of the rheumatic diseases.

[Therapy of rheumatoid arthritis with methotrexate. Claims data analysis of treatment patterns].

H. Zeidler, J. Zeidler, J. Graf von der Schulenburg, 2012, Zeitschrift für Rheumatologie (Print).

The modulation of chlamydial replication by HLA-B27 depends on the cytoplasmic domain of HLA-B27.

H. Zeidler, M. Ikeda, D. Yu, 2001, Clinical and experimental rheumatology.

Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance

H. Zeidler, 2013, Annals of the rheumatic diseases.

Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al

H. Zeidler, 2016, Annals of the rheumatic diseases.

Identification of candidate genes for susceptibility to reactive arthritis

P. Tak, H. Zeidler, R. Schmidt, 2009, Rheumatology International.

Undifferentiated arthritis and reactive arthritis.

H. Zeidler, J. Wollenhaupt, 1998, Current opinion in rheumatology.

Reply to: Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study

H. Zeidler, 2012, Annals of the Rheumatic Diseases.

Benign polyarthritis and undifferentiated arthritis an epidemiological terra incognita.

H. Zeidler, J. Hülsemann, 1989, Scandinavian Journal of Rheumatology. Supplement.

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

M. Dougados, S. van der Linden, R. Juhlin, 1991, Arthritis and rheumatism.

Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10 year follow-up.

H. Zeidler, H. Deicher, W. Stangel, 1990, Zeitschrift fur Rheumatologie.

Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.

M. Dougados, A. Calin, J. Nakache, 1999, The Journal of rheumatology.

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany

Matthias Schneider, H. Zeidler, E. Gromnica-ihle, 2012, PharmacoEconomics.

Manifestations of Chlamydia induced arthritis in patients with silent versus symptomatic urogenital chlamydial infection.

H. Zeidler, J. Wollenhaupt, T. Krech, 1995, Clinical and experimental rheumatology.

Increased frequency of HLA-Bw62 and Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis.

H. Zeidler, H. Deicher, P. Wagener, 1984, Zeitschrift fur Rheumatologie.

Identification of interleukin-7 as a candidate disease mediator in spondylarthritis.

P. Tak, H. Zeidler, D. Baeten, 2008, Arthritis and rheumatism.

Undifferentiated arthritis and spondylarthropathy as a challenge for prospective follow-up

H. Zeidler, J. Hülsemann, S. Brinkmann, 1987, Clinical Rheumatology.

The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress

B. Amor, H. Zeidler, 2010, Annals of the rheumatic diseases.

[Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)].

H Raspe, R Dreher, H. Raspe, 2011, Zeitschrift fur Rheumatologie.

The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes.

E. Märker-Hermann, H. Zeidler, M. Ikeda, 2002, Clinical and Experimental Rheumatology.